| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/19/2014 | WO2014093396A1 Anti-blood dendritic cell antigen 2 antibodies and uses thereof |
| 06/19/2014 | WO2014093203A1 SOLUTION FORMULATIONS OF ENGINEERED ANTI-IL-23p19 ANTIBODIES |
| 06/19/2014 | WO2014092227A1 Composition for treatment of diseases related to removal of extracellular alpha-synuclein and method for screening therapeutic agent for said diseases |
| 06/19/2014 | WO2014091034A1 Novel mhc-independent tumor-associated antigens |
| 06/19/2014 | WO2014090865A1 Anti-influenza antibody |
| 06/19/2014 | WO2014090053A1 Monoclonal antibody for antagonizing and inhibiting binding of vascular endothelial cell growth factor and its receptor, and coding sequence and use thereof |
| 06/19/2014 | WO2014001324A9 Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof |
| 06/19/2014 | WO2013166448A8 Stable formulations containing anti-pcsk9 antibodies |
| 06/19/2014 | WO2013068563A9 Antibody molecules having specificity for human ox40 |
| 06/19/2014 | US20140171634 Stable and soluble antibodies inhibiting tnf alpha |
| 06/19/2014 | US20140171624 Modulators of adp-dependent glucokinase (adpgk) and glycerol-3-phosphate dehydrogenase (gpd2) for therapy |
| 06/19/2014 | US20140171623 Modulation Of Antibody Effector Function By Hinge Domain Engineering |
| 06/19/2014 | US20140171622 Fusion proteins forming trimers |
| 06/19/2014 | US20140171621 Galectin-Immunoglobulin Chimeric Molecules |
| 06/19/2014 | US20140171594 Stimulus responsive polymers for the purification of biomolecules |
| 06/19/2014 | US20140171373 Compositions and methods related to tauopathy |
| 06/19/2014 | US20140170727 Affinity medium using fixed whole cells |
| 06/19/2014 | US20140170705 Methods of generating libraries and uses thereof |
| 06/19/2014 | US20140170704 Production of Carrier-Peptide Conjugates Using Chemically Reactive Unnatural Amino Acids |
| 06/19/2014 | US20140170681 Novel anti-cxcr4 antibody and its use for the detection and diagnosis of cancer |
| 06/19/2014 | US20140170677 Use of the antibody i-3859 for the detection and diagnosis of cancer |
| 06/19/2014 | US20140170668 Monoclonal and oligoclonal anti-egfr antibodies for use in the treatment of tumors expressing predominantly high affinity egfr ligands or tumors expressing predominantly low affinity egfr ligands |
| 06/19/2014 | US20140170658 Mammalian cytokines; related reagents |
| 06/19/2014 | US20140170643 PARP Substrates and Biomarkers |
| 06/19/2014 | US20140170170 Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof |
| 06/19/2014 | US20140170168 Antibodies which bind soluble t-cell receptor ligands |
| 06/19/2014 | US20140170167 Inhibition of Bone Resorption with Rankl Binding Peptides |
| 06/19/2014 | US20140170166 Antigen binding proteins that bind par-2 |
| 06/19/2014 | US20140170164 Yersinia spp. Polypeptides and Methods of Use |
| 06/19/2014 | US20140170163 Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof |
| 06/19/2014 | US20140170161 BMP-6 Antibodies |
| 06/19/2014 | US20140170160 Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor |
| 06/19/2014 | US20140170159 Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof |
| 06/19/2014 | US20140170156 Human monoclonal antibodies against interleukin 8 (il-8) |
| 06/19/2014 | US20140170155 Method for Treating a GD2 Positive Cancer |
| 06/19/2014 | US20140170154 Engineered anti-il-23r antibodies |
| 06/19/2014 | US20140170153 Il-21 epitope and il-21 ligands |
| 06/19/2014 | US20140170152 Immunobinders directed against tnf |
| 06/19/2014 | US20140170150 N-linked glycan compounds |
| 06/19/2014 | US20140170149 Bispecific antibodies against her2 and cd3 |
| 06/19/2014 | US20140170148 Bispecific antibodies against her2 |
| 06/19/2014 | US20140170147 Compositions and methods of use for antibodies of dickkopf-1 |
| 06/19/2014 | US20140170145 Compositions and methods of use for mgd-csf in disease treatment |
| 06/19/2014 | US20140170144 Antibody recognizing n-domain of midkine |
| 06/19/2014 | US20140170143 Use of an anti-cd200 antibody for prolonging the survival of allografts |
| 06/19/2014 | US20140170142 Molecules With Extended Half-Lives And Uses Thereof |
| 06/19/2014 | US20140170141 Polypeptides and uses thereof for treatment of autoimmune disorders and infection |
| 06/19/2014 | US20140170140 Compositions and methods for the treatment of neuromyelitis optica |
| 06/19/2014 | US20140170138 Humanized antibodies specific for hsp65-derived peptide-6, methods and uses thereof |
| 06/19/2014 | US20140170137 Therapeutic canine immunoglobulins and methods of using same |
| 06/19/2014 | US20140170136 Anti-nerve growth factor antibodies and methods of preparing and using the same |
| 06/19/2014 | US20140170134 Compositions and methods related to antibodies to staphylococcal protein a |
| 06/19/2014 | US20140170114 Glypican-3-specific antibody and uses thereof |
| 06/19/2014 | US20140170109 Il-12 immunoconjugate |
| 06/19/2014 | US20140170108 Compositions useful for the treatment of inflammatory disease or disorders |
| 06/19/2014 | US20140170065 Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments |
| 06/19/2014 | US20140170064 Methods and compositions for radiohalogen protein labeling |
| 06/18/2014 | EP2743699A1 Method for testing for, preventing, and treating infectious disease aspergillus fumigatus, and composition |
| 06/18/2014 | EP2743697A2 Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas |
| 06/18/2014 | EP2743348A1 Novel anti-human ngf antibody |
| 06/18/2014 | EP2742361A1 Angiopoietin-like 4 and its use in modulating cell leakiness |
| 06/18/2014 | EP2742068A1 New antibodies against phosphorylcholine |
| 06/18/2014 | EP2742067A2 Anti-fzd10 monoclonal antibodies and methods for their use |
| 06/18/2014 | EP2741774A2 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
| 06/18/2014 | EP2741773A1 Methods of treating progressive forms of multiple sclerosis |
| 06/18/2014 | EP2484756A9 Novel pacemaker cell |
| 06/18/2014 | CN103874925A Method for detecting matrix metalloproteinase-3 by latex agglutination method |
| 06/18/2014 | CN103874710A Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair |
| 06/18/2014 | CN103874709A Anti-tie2 antibodies uses thereof |
| 06/18/2014 | CN103874708A Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
| 06/18/2014 | CN103874707A Neutralizing anti-CCL20 antibodies |
| 06/18/2014 | CN103866401A Aflatoxin nano antibody gene pool, construction method and application of aflatoxin nano antibody gene pool as well as aflatoxin B1 nano antibody 2014AFB-G15 |
| 06/18/2014 | CN103865950A Induced expression and purification method of human-derived insulin-like growth factor binding protein 1 in pichia pastoris, and preparation and application of related antibodies |
| 06/18/2014 | CN103865938A Establishment method of clostridium difficile exotoxin A carboxyl-terminal sequence codon optimization gene segment and expression vector and application of expression protein thereof |
| 06/18/2014 | CN103865934A Bungatotoxin antigen epitope gene and application of bungatotoxin antigen epitope gene to preparation of gene vaccine and antigen |
| 06/18/2014 | CN103865884A Duck viral hepatitis bivalent yolk antibody, preparation method and application thereof |
| 06/18/2014 | CN103865883A Monoclonal antibodies for resisting high-risk human papillomavirus proteins and application of monoclonal antibodies |
| 06/18/2014 | CN103865882A Monoclonal antibody of alpha-galactosidase and application thereof |
| 06/18/2014 | CN103865881A Hybridoma cell capable of secreting protein monoclonal antibody resisting hepatitis virus A and application |
| 06/18/2014 | CN103865878A Monoclonal antibody for antagonistic inhibition of combination of vascular endothelial cell growth factor and receptor thereof, hybridoma cell line secreting monoclonal antibody, and use of monoclonal antibody |
| 06/18/2014 | CN103864935A Targeted EGFR/KDR (Epidermal Growth Factor Receptor/Kinase Insert Domain Receptor) specific diabody |
| 06/18/2014 | CN103864934A Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 06/18/2014 | CN103864933A Goose alpha-interferon single-chain antibody as well as preparation method and application thereof |
| 06/18/2014 | CN103864932A Monoclonal antibody for antagonistically inhibiting combination of vascular endothelial growth factor with its receptor, and coding sequence and use thereof |
| 06/18/2014 | CN103864931A Preparation and freeze-dried storage method of pseudorabies standard positive serum |
| 06/18/2014 | CN103864930A Preparation and use method of antibody resisting scorpion venom of buthus martensii karsch in China F (ab') 2 |
| 06/18/2014 | CN103864929A Preparation method of beta-casein monoclonal antibody, beta-casein colloidal gold test strip and preparation method thereof |
| 06/18/2014 | CN103864928A Preparation of common antigen monoclonal antibody of Brucella sLPS (lipopolysaccharides) and establishment of c-ELISA (competitive enzyme-linked immuno sorbent assay)method |
| 06/18/2014 | CN103864927A Single-domain antibody coding sequences of retinol binding proteins (RBP) and application of coding sequence |
| 06/18/2014 | CN103864926A Method for preparing rabies human immune globulin by inactivation of double viruses |
| 06/18/2014 | CN103864925A Heavy chain and light chain variable region of high-neutralizing activity anti-Japanese encephalitis virus (JEV) monoclonal antibody |
| 06/18/2014 | CN103864924A Middle east and respiratory syndrome coronavirus antibody and preparation method thereof |
| 06/18/2014 | CN103864923A Glycosylated antibodies |
| 06/18/2014 | CN103864907A Protein and kit for tuberculosis diagnosis |
| 06/18/2014 | CN103864904A Antigen fragment and truncation based on ebola virus envelope protein as well as application |
| 06/18/2014 | CN103204936B Preparation method for polyclonal antibody to salmonella effect protein SopB |
| 06/18/2014 | CN103012587B Preparation, identification and application of monoclonal antibody of specific human lung resisting specific X protein |
| 06/18/2014 | CN102757496B Method for purifying and preparing anti-VEGF antibody fragment |
| 06/18/2014 | CN102732533B Vaccine produced by using Cryptocaryon irritans immbolization antigen to complement deoxyribonucleic acid, and production method and application thereof |
| 06/18/2014 | CN102596996B Antibody having activity of inhibiting infection with hepatitis c virus (HCV) and use of same |